Cardiovascular Cell Therapy Case Reports
Cardiovascular cell therapy for coronary heart disease represents an exciting yet highly debated field within regenerative cardiology. Although clinical trials have progressed significantly, many scientific uncertainties remain—particularly regarding cardiomyocyte turnover, mechanisms of cardiac repair, and the most effective strategies to achieve meaningful clinical benefit.
Our Case Reports and Case Series in Cardiology Journal welcomes detailed case reports that highlight real-world applications, challenges, and outcomes related to cardiovascular cell therapy.
Scope of Submissions We Publish
1. Stem Cell–Based Interventions
-
Bone marrow–derived stem cells
-
Mesenchymal stem cells
-
Adipose-derived regenerative cells
-
Induced pluripotent stem cell–based therapies
2. Applications in Coronary Heart Disease
-
Post–myocardial infarction regeneration
-
Chronic ischemic cardiomyopathy
-
Heart failure with reduced ejection fraction
-
Refractory angina
3. Clinical Challenges & Observations
-
Low cell retention after delivery
-
Limited differentiation into cardiomyocytes
-
Variable and modest improvements in function
-
Safety outcomes and complication profiles
4. Emerging Approaches
-
Direct myocardial injection
-
Intracoronary delivery techniques
-
Tissue-engineered scaffolds
-
Gene-enhanced cell therapy
5. Areas of Debate
-
True cardiogenic potential of delivered cells
-
Mechanisms of benefit (paracrine vs direct regeneration)
-
Optimal cell type and dose
-
Long-term clinical effectiveness
Manuscript Submission
Authors are requested to submit their manuscript by using Online Manuscript Submission Portal: https://www.casereportsincardiology.org/submit.html (or) also invited to submit through the Journal E-mail Id: editor@casereportsincardiology.org.